Skip to content
For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application.

10% off all research materials

Ends soon

Log in
BeSkinny Research
Research use only
Body Pharm CagriSema 12mg Pen — solution, pre-filled multi-dose research pen, research use only

Research use only

For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application. This product is not a medicine, food, dietary supplement or cosmetic, and no medical, therapeutic or performance claims are made or implied. Sold only to purchasers aged 18+ for laboratory research. Read our research-use policy.

Body Pharm CagriSema 12mg Pen

Solution, pre-filled multi-dose research pen · 12 mg (6 mg cagrilintide + 6 mg semaglutide) · Research use only

  • Amylin / calcitonin receptors
  • GLP-1R
  • Receptor co-activation

R2 500.00R2 000.00On sale

SKU bpcagri12 · In stock

A cagrilintide (amylin analogue) and semaglutide (GLP-1 receptor agonist) blend supplied as a 12 mg pre-filled research pen for receptor co-activation research.

1

Card · Tracked delivery in South Africa

Research-use declaration (18+) required at checkout.

Description

CagriSema is a research blend of two peptides: cagrilintide, a long-acting acylated amylin analogue that acts at amylin (AMY) and calcitonin receptors, and semaglutide, a GLP-1 receptor agonist. This pen contains 6 mg cagrilintide and 6 mg semaglutide (12 mg total peptide).

The combination is used in laboratory studies of amylin and GLP-1 receptor co-activation, receptor cross-talk and preclinical metabolic signalling. It has been evaluated in the REDEFINE clinical development programme.

Supplied by Body Pharm as a pre-filled multi-dose research pen containing 6 mg cagrilintide and 6 mg semaglutide in solution, with a batch Certificate of Analysis. Store at 2-8 °C, protected from light; do not freeze.

For laboratory research use only. Not for human or veterinary use, diagnosis, treatment or any clinical application.

Specification

CompoundCagriSema
Declared quantity12 mg (6 mg cagrilintide + 6 mg semaglutide)
FormatSolution, pre-filled multi-dose research pen
SynonymsCagrilintide + semaglutide
Certificate of AnalysisAvailable on request
StorageStore at 2-8 °C, protected from light. Do not freeze.
Intended useLaboratory research use only. Not for human or veterinary use.

More in Incretin Receptor Research Peptides.